255 related articles for article (PubMed ID: 24714398)
1. Glucotoxicity targets hepatic glucokinase in Zucker diabetic fatty rats, a model of type 2 diabetes associated with obesity.
Ueta K; O'Brien TP; McCoy GA; Kim K; Healey EC; Farmer TD; Donahue EP; Condren AB; Printz RL; Shiota M
Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1225-38. PubMed ID: 24714398
[TBL] [Abstract][Full Text] [Related]
2. Glucose toxicity is responsible for the development of impaired regulation of endogenous glucose production and hepatic glucokinase in Zucker diabetic fatty rats.
Fujimoto Y; Torres TP; Donahue EP; Shiota M
Diabetes; 2006 Sep; 55(9):2479-90. PubMed ID: 16936196
[TBL] [Abstract][Full Text] [Related]
3. Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats.
Torres TP; Catlin RL; Chan R; Fujimoto Y; Sasaki N; Printz RL; Newgard CB; Shiota M
Diabetes; 2009 Jan; 58(1):78-86. PubMed ID: 18952838
[TBL] [Abstract][Full Text] [Related]
4. Correcting Postprandial Hyperglycemia in Zucker Diabetic Fatty Rats With an SGLT2 Inhibitor Restores Glucose Effectiveness in the Liver and Reduces Insulin Resistance in Skeletal Muscle.
O'Brien TP; Jenkins EC; Estes SK; Castaneda AV; Ueta K; Farmer TD; Puglisi AE; Swift LL; Printz RL; Shiota M
Diabetes; 2017 May; 66(5):1172-1184. PubMed ID: 28246292
[TBL] [Abstract][Full Text] [Related]
5. Defect in glucokinase translocation in Zucker diabetic fatty rats.
Fujimoto Y; Donahue EP; Shiota M
Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E414-23. PubMed ID: 15138155
[TBL] [Abstract][Full Text] [Related]
6. Defective glycogenesis contributes toward the inability to suppress hepatic glucose production in response to hyperglycemia and hyperinsulinemia in zucker diabetic fatty rats.
Torres TP; Fujimoto Y; Donahue EP; Printz RL; Houseknecht KL; Treadway JL; Shiota M
Diabetes; 2011 Sep; 60(9):2225-33. PubMed ID: 21771972
[TBL] [Abstract][Full Text] [Related]
7. A defect in glucose-induced dissociation of glucokinase from the regulatory protein in Zucker diabetic fatty rats in the early stage of diabetes.
Shin JS; Torres TP; Catlin RL; Donahue EP; Shiota M
Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1381-90. PubMed ID: 17204595
[TBL] [Abstract][Full Text] [Related]
8. Cocoa-rich diet ameliorates hepatic insulin resistance by modulating insulin signaling and glucose homeostasis in Zucker diabetic fatty rats.
Cordero-Herrera I; Martín MÁ; Escrivá F; Álvarez C; Goya L; Ramos S
J Nutr Biochem; 2015 Jul; 26(7):704-12. PubMed ID: 25814291
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the effect of canagliflozin on renal glucose reabsorption and progression of hyperglycemia in zucker diabetic Fatty rats.
Kuriyama C; Xu JZ; Lee SP; Qi J; Kimata H; Kakimoto T; Nakayama K; Watanabe Y; Taniuchi N; Hikida K; Matsushita Y; Arakawa K; Saito A; Ueta K; Shiotani M
J Pharmacol Exp Ther; 2014 Nov; 351(2):423-31. PubMed ID: 25216746
[TBL] [Abstract][Full Text] [Related]
10. Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation.
Farrelly D; Brown KS; Tieman A; Ren J; Lira SA; Hagan D; Gregg R; Mookhtiar KA; Hariharan N
Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14511-6. PubMed ID: 10588736
[TBL] [Abstract][Full Text] [Related]
11. Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models.
Liang Y; Arakawa K; Ueta K; Matsushita Y; Kuriyama C; Martin T; Du F; Liu Y; Xu J; Conway B; Conway J; Polidori D; Ways K; Demarest K
PLoS One; 2012; 7(2):e30555. PubMed ID: 22355316
[TBL] [Abstract][Full Text] [Related]
12. Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats.
Nawano M; Oku A; Ueta K; Umebayashi I; Ishirahara T; Arakawa K; Saito A; Anai M; Kikuchi M; Asano T
Am J Physiol Endocrinol Metab; 2000 Mar; 278(3):E535-43. PubMed ID: 10710509
[TBL] [Abstract][Full Text] [Related]
13. Glucokinase gene transfer to skeletal muscle of diabetic Zucker fatty rats improves insulin-sensitive glucose uptake.
Jiménez-Chillarón JC; Telemaque-Potts S; Gómez-Valadés AG; Anderson P; Newgard CB; Gómez-Foix AM
Metabolism; 2002 Jan; 51(1):121-6. PubMed ID: 11782883
[TBL] [Abstract][Full Text] [Related]
14. Berberine alleviates hyperglycemia by targeting hepatic glucokinase in diabetic db/db mice.
Li M; Dang Y; Li Q; Zhou W; Zuo J; Yao Z; Zhang L; Ji G
Sci Rep; 2019 May; 9(1):8003. PubMed ID: 31142783
[TBL] [Abstract][Full Text] [Related]
15. Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production.
Barzilai N; Hawkins M; Angelov I; Hu M; Rossetti L
Diabetes; 1996 Oct; 45(10):1329-35. PubMed ID: 8826967
[TBL] [Abstract][Full Text] [Related]
16. Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors.
Lloyd DJ; St Jean DJ; Kurzeja RJ; Wahl RC; Michelsen K; Cupples R; Chen M; Wu J; Sivits G; Helmering J; Komorowski R; Ashton KS; Pennington LD; Fotsch C; Vazir M; Chen K; Chmait S; Zhang J; Liu L; Norman MH; Andrews KL; Bartberger MD; Van G; Galbreath EJ; Vonderfecht SL; Wang M; Jordan SR; Véniant MM; Hale C
Nature; 2013 Dec; 504(7480):437-40. PubMed ID: 24226772
[TBL] [Abstract][Full Text] [Related]
17. For the ZDF rat, "Breaking up is hard to do": dissociation of the GK:GKRP complex.
Lange AJ
Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1379-80. PubMed ID: 17185403
[No Abstract] [Full Text] [Related]
18. The impact of glucagon to support postabsorptive glucose flux and glycemia in healthy rats and its attenuation in male Zucker diabetic fatty rats.
Estes SK; Shiota C; O'Brien TP; Printz RL; Shiota M
Am J Physiol Endocrinol Metab; 2024 Mar; 326(3):E308-E325. PubMed ID: 38265288
[TBL] [Abstract][Full Text] [Related]
19. Diazoxide attenuates insulin secretion and hepatic lipogenesis in zucker diabetic fatty rats.
Alemzadeh R; Tushaus K
Med Sci Monit; 2005 Dec; 11(12):BR439-48. PubMed ID: 16319780
[TBL] [Abstract][Full Text] [Related]
20. The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats.
Steven S; Oelze M; Hanf A; Kröller-Schön S; Kashani F; Roohani S; Welschof P; Kopp M; Gödtel-Armbrust U; Xia N; Li H; Schulz E; Lackner KJ; Wojnowski L; Bottari SP; Wenzel P; Mayoux E; Münzel T; Daiber A
Redox Biol; 2017 Oct; 13():370-385. PubMed ID: 28667906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
